THE LOW CARB DIABETIC

Would you like to react to this message? Create an account in a few clicks or log in to continue.
THE LOW CARB DIABETIC

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.


Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

    Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC

    graham64
    graham64
    Member


    Status :
    Online
    Offline

    Male Posts : 3730
    Join date : 2014-08-10
    Location : Lancs

    Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC Empty Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC

    Post by graham64 Mon Jan 26 2015, 22:42

    Abstract

    The Diabetes Control and Complications Trial (DCCT) demonstrated that a mean of 6.5 years of intensive therapy aimed at near normal glucose levels reduced the risk of development and progression of retinopathy by as much as 76% compared to conventional therapy.

    The Epidemiology of Diabetes Interventions and Complications (EDIC) observational follow-up showed that the risk of further progression of retinopathy 4 years after the DCCT ended was also greatly reduced in the former intensive group, despite nearly equivalent levels of HbA1c, a phenomenon termedmetabolic memory.

    Metabolic memory was shown to persist through 10 years of follow-up. We now describe the risk of further progression of retinopathy, progression to proliferative diabetic retinopathy, clinically significant macular edema and the need for intervention (photocoagulation or anti-VEGF) over 18 years of follow-up in EDIC.

    The cumulative incidence of each retinal outcome continues to be lower in the former intensive group. However, the year-to-year incidence of these outcomes is now similar, owing in large part to a reduction in risk in the former conventional treatment group.

    http://diabetes.diabetesjournals.org/content/early/2014/09/05/db14-0930.abstract


      Current date/time is Fri Mar 29 2024, 00:24